Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital

NCT06681363 · tracked via the Priya Life Science France tracker

Sponsor

Nantes University Hospital

Phase

Observational

Started

2026-05-21

Last updated

2026-05-29

Condition(s) studied

Acute Myeloid LeucemiaHigh-risk Myelodysplastic Syndrome (MDS)Acute Lymphoid Leukemia

Study summary

The aim of the LANA bio-collection is to collect samples from patients with Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL) or or high-risk myelodysplastic syndrome (MDS) to facilitate access to the leukemic or myelodysplastic cells for the research teams of the National Institute of Health and Medical Research (INSERM). To do this, an additional blood or bone marrow sample to those planned in the context of patient care will be collected after signing consent. These samples will then be sent directly to the INSERM teams for immediate analysis with the aim to conduct research aimed at a better understanding of AML, ALL or MDS and improving treatments

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patient of legal age affected by AML, ALL or MDS regardless of the time of treatment * Patient who has signed the consent form. * Patient affiliated with a social security system. Exclusion Criteria: * Minor patients. * Adults under guardianship. * Protected persons

Primary outcome measure(s)

Characterization of the tumor and its microenvironment for AML, ALL or MDS in order to identify novel biomarkers or therapeutic targets — One year after inclusion
Identify genetic polymorphisms associated with an increased risk of developing AML or ALL

Trial sites (1)

Facility	City	Region	Status
Nantes University Hospital	Nantes	France	Recruiting

More Nantes University Hospital trials in France

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation Recruiting

Research Project on the Risk of Discomfort, Pain, Alteration of Skin Condition in Bedpan Use by Patients and Caregivers Recruiting

Advanced Practice Nurses for Fall Incidence PrevenTion in Very Old Robust Adults Recruiting

Optimization of Skin Preparation to Reduce Cutibacterium Acnes Colonization in Superficial and Deep Samples During Prosthetic Shoulder Surgery in Male Patients Recruiting

Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis Active, not recruiting

Other trials for the same condition

Study of the Medullary Microenvironment in Acute Childhood Leukemia Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06681363 on ClinicalTrials.gov ↗ ← All trials in France